You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Locating the Elderly Overseen by Nurses- LEON

    SBC: Q-Track Corporation            Topic: NIA

    DESCRIPTION (provided by applicant): The proposed effort aims to develop a comprehensive wireless tracking and monitoring system for residents of Long Term Care facilities. The commercial product ElderAlertTM extends Q-Track's real-time location system totrack residents, caregivers, and medical assets within a LTC facility. ElderAlertTM directs caregivers to residents who have fallen or have ...

    SBIR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health
  2. A NOVEL MICROFLUIDIC DEVICE FOR SELECTION AND OPTIMIZATION OF DRUG DELIVERY VEHIC

    SBC: CFD RESEARCH CORPORATION            Topic: NCI

    DESCRIPTION (provided by applicant): We propose to develop and demonstrate a novel microfluidic device and assay for selection and optimization of delivery vehicles, specifically non-viral vectors for drug delivery to tumors. Tumor drug delivery is a complex phenomenon affected by several elements in addition to drug or delivery vehicle's physico-chemical properties. A key factor is tumor mic ...

    SBIR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health
  3. New In Vitro Human Liver Toxicity Bioassay System

    SBC: Vivo Biosciences Inc            Topic: NIEHS

    DESCRIPTION (provided by applicant): The overall objective of this SBIR proposal is to develop and commercialize a human 3D or mini- liver bioassay system suitable for real-time analysis of metabolic functions and long-term drug toxicity profiles. At present, liver functions are mostly studied using HepG2 cell line and primary hepatocytes cultured onto collagen or polymer matrices. However, these ...

    SBIR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health
  4. A novel physiologically realistic microfluidic in-vitro blood-brain barrier model

    SBC: CFD RESEARCH CORPORATION            Topic: NIGMS

    DESCRIPTION (provided by applicant): The overall objective of this study is to develop a novel in vitro microfluidic platform to test a drug or delivery vehicle's ability to permeate the Blood-Brain Barrier (BBB). In contrast to current in-vitro models, our proposed device, SIM-BBB, comprises of a microfluidic two-compartment chamber. The chamber is designed in such a way as to permit vis ...

    SBIR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health
  5. Design and development of a multifunctional self-service health screening kiosk

    SBC: Pursuant HEALTH, INC.            Topic: NIMHD

    DESCRIPTION (provided by applicant): This Fast-Track SBIR proposal submitted by SoloHealth of Duluth, Georgia, requests grant funds to build and test a multifunction health-screening kiosk. Our current kiosk prototype, EyeSite, has demonstrated efficacy inreaching low income, high health disparity populations with over 109,000 uses in less than 9 months of testing. Our goal is to expand the offeri ...

    SBIR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health
  6. Toda Promotora Clearinghouse: Supporting nonprofits' use of promotores

    SBC: KDH Research & Communication, Inc.            Topic: NIMHD

    DESCRIPTION (provided by applicant): The objective of this Fast Track Small Business Innovation Research application, submitted by KDH Research and Communication (KDHRC), is to develop and evaluate an online information clearinghouse to support community-based nonprofit organizations' (NPOs) use of promotores programs to provide health information to underserved Latinos. Promotores programs u ...

    SBIR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health
  7. GPU-enhanced Neuroscience Software Tools

    SBC: Accelereyes LLC            Topic: NIMH

    DESCRIPTION (provided by applicant): This application is to deliver high-performance, GPU-enabled computation and visualization software tools to neuroscientists. Today, there are an estimated 1.5 million life science MATLAB users, with a substantial portion of those using MATLAB to solve neuroscience-related problems. MATLAB users, especially those dealing with large neuroscience datasets, such a ...

    SBIR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health
  8. Pre-clinical Development of a Context-Dependent NMADR Neuroprotectant for Treatme

    SBC: NEUROP, INC.            Topic: NINDS

    DESCRIPTION (provided by applicant): Cerebral ischemia is a major cause of death and long-term disability, with high accompanying social and medical costs. Approximately 795,000 Americans suffer a stroke each year at an estimated annual cost of 73.7B (American Heart Association. Heart Disease and Stroke Statistics, 2010 Update). Substantial preclinical data support the use of NMDA receptor antago ...

    SBIR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health
  9. A novel live intranasal TB vaccine

    SBC: PATHENS, INC.            Topic: NIAID

    DESCRIPTION (provided by applicant): The most-widely used vaccine for TB currently is BCG, a live avirulent variant of M. bovis that is given intradermally at birth. Along with the inherent safety and logistical problems associated with being injected, protective efficacy is generally poor and wanes by adolescence. BCG administration to an immunosuppressed individual also can disseminate and lead ...

    STTR Phase I 2012 Department of Health and Human ServicesNational Institutes of Health
  10. Site-specific O-GlcNAc MAbs: New Tools for Glycoproteomics

    SBC: GLYCOSCIENTIFIC, L.L.C.            Topic: NIGMS

    DESCRIPTION (provided by applicant): O-glycosylation of serine and threonine of nuclear and cytoplasmic proteins by a single beta-N- acetyl-D-glucosamine moiety (O-GlcNAc) is a ubiquitous post-translational modification that is highly dynamic and fluctuates in response to cellular stimuli. O-GlcNAc often competes with protein phosphorylation, and these two modifications have extensive crosstalk in ...

    STTR Phase I 2012 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government